Making stem cells count for global health

Regenerative Medicine

Volumn 6, Issue 6 SUPPL., 2011, Pages 163-166

  McMahon, Dominique S ^a   Thorsteinsdóttir, Halla ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAZIL; CELL THERAPY; CHINA; CORNEA LIMBUS; DEVELOPING COUNTRY; HEALTH CARE NEED; HUMAN; INDIA; LIMBAL STEM CELL TRANSPLANTATION; MEDICAL RESEARCH; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL RESEARCH; TRANSLATIONAL RESEARCH;

BRAZIL; CHINA; DEVELOPING COUNTRIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONAL COOPERATION; INVESTMENTS; PEER REVIEW, RESEARCH; PUBLISHING; REGENERATIVE MEDICINE; STEM CELLS; WORLD HEALTH;

EID: 80054119228     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.67     Document Type: Review

References (11)

1. McMahon DS, Thorsteinsdóttir H, Singer PA, Daar AS. Cultivating regenerative medicine innovation in China. Regen. Med. 5(1), 35-44 (2010). □□ Presents an ana lysis of regenerative medicine innovation in China, including its sucesses and challenges.
2. Sogayar MC, Campos de Carvalho AC. Stem cell research in Brazil: incentives, barriers and perspectives. In: World Stem Cell Report. Genetics Policy Institute, FL, USA, 179-184 (2010).
3. Leite M. Overcoming opposition: Brazil banks on stem cells. Science 324(5923), 26-26 (2009).
4. Greenwood H, Singer P, Downey G, Martin D, Thorsteinsdóttir H, Daar A. Regenerative medicine and the developing world. PLoS Med. 3(9), e381 (2006). □□ Identifies the most relevant applications for regenerative medicine in the developing world, demonstrating the relevance of stem cells to local health needs.
5. Greenwood HL, Thorsteinsdóttir H, Perry G, Renihan J, Singer PA, Daar AS. Regenerative medicine: new opportunities for developing countries. Int. J. Biotechnol. 8(1), 60-77 (2006).
6. McMahon DS, Singer PA, Daar AS, Thorsteinsdóttir H. Regenerative medicine in Brazil: small but innovative. Regen. Med. 5(6), 863-876 (2010). □□ Presents an ana lysis of regenerative medicine innovation in Brazil, including its sucesses and challenges.
7. Lander B, Thorsteinsdóttir H, Singer PA, Daar AS. Harnessing stem cells for health needs in India. Cell Stem Cell 3(1), 11-15 (2008). □□ Presents an ana lysis of regenerative medicine innovation in India, including its sucesses and challenges.
8. Jamison DT Investing in Health. In: Disease Control Priorities in Developing Countries. Jamison DT, Breman JG, Measham AR et al. (Eds). World Bank, DC, USA, 1-42 (2006).
9. Polanczyk C, Ribeiro J. Coronary artery disease in Brazil: contemporary management and future perspectives. Heart 95(11), 870-876 (2009).
10. Tura B, Martino H, Gowdak L et al. Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. Trials 8, 2 (2007).
11. Gajewski J, Robinson P. Do affluent societies have the only options for the best therapy? Leukemia 21(3), 387-388 (2007). □□ Presents key diferences in bone marrow transplant protocols between developed countries with China and India. These diferences make locally developed protocols more culturally relevant and afordable.